Por: CBS News Health March 10, 2023
Pfizer said Friday that the Food and Drug Administration has approved a new nasal spray to treat migraines.Zavzpret, a branded formulation of the generic drug zavegepant, is the first and only calcitonin gene-related peptide receptor antagonist nasal spray for treating migraines with or without an aura, or sensory disturbances such as flashes of that can accompany a migraine, the drugmaker said. Zavzpret began working to treat migraine... + full article
New York Post USA Life March 29, 2023
On Wednesday, the Food and Drug Administration approved the first over-the-counter nasal spray that rapidly reverses the effects of an opioid overdose. Narcan, a 4-milligram naloxone hydrochloride nasal spray, will not require a prescription and will be available in... + más
FDA approves first over-the-counter Narcan | Politico
F.D.A. Approves Narcan for Over-the-Counter Sales | The New York Times
ABC7 USA Health March 11, 2023
The U.S. Food and Drug Administration has approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant) - the first and only migraine treatment of its kind to be offered in nasal spray.The drug has shown in clinical trial data to provide rapid pain relief in... + más
FDA approves Prizer's Zavzpret, first of its kind migraine treatment nasal spray | ABC7
FDA approves Pfizer's new nasal spray treatment for migraines | ABC News
ABC News USA Health March 11, 2023
The U.S. Food and Drug Administration has approved Pfizer's newest drug on the market, Zavzpret (zavegepant) -- the first and only migraine treatment of its kind to be offered in nasal spray.The drug has shown in clinical trial data to provide rapid pain relief in as fast... + más
F.D.A. Approves New Nasal Spray for Migraines | The New York Times
FDA Approves a New Nasal Spray to Treat Migraines | Time
The New York Times USA Health March 11, 2023
The Food and Drug Administration has approved a Pfizer nasal spray for treatment of migraines that uses a different therapy from other nasal products on the market for severe headache pain, the company said on Friday.The fast-acting treatment, which is called zavegepant and will... + más
New York Daily News USA Health March 11, 2023
The U.S. Food and Drug Administration has approved a nasal spray developed by Pfizer as a means to quickly treat the painful symptoms associated with suffering a migraine. The drug, Zavzpret, also known as zavegepant, was approved on Thursday for the treatment of acute migraines... + más
Time USA Health March 10, 2023
On Mar. 10, the U.S. Food and Drug Administration (FDA) a new treatment for migraines given as a nasal spray, according to the drug’s maker, Pfizer. Zavegepant (brand name: Zavzpret), is the first of a class of migraine treatments known as calcitonin gene-related peptide... + más
About iurex | Privacy Policy | Disclaimer |